![Thomas Kudsk Larsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Kudsk Larsen
Investor Relations Kontakt bei SANOFI
Profil
Thomas Kudsk Larsen is currently the Head-Investor Relations at Sanofi.
Previously, he worked as an Investor Relations Contact at AstraZeneca PLC.
From 2011 to 2014, he served as the Head-Investor Relations North America at Roche Holdings, Inc. In the future, from 2021 to 2023, he will be the Head-Communication & Investor Relations at Swedish Orphan Biovitrum AB.
Mr. Larsen completed his undergraduate degree at Copenhagen Business School.
Aktive Positionen von Thomas Kudsk Larsen
Unternehmen | Position | Beginn |
---|---|---|
SANOFI | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Thomas Kudsk Larsen
Unternehmen | Position | Ende |
---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Investor Relations Kontakt | 01.04.2023 |
ASTRAZENECA PLC | Investor Relations Kontakt | 01.08.2021 |
Roche Holdings, Inc.
![]() Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Investor Relations Kontakt | 01.09.2014 |
Ausbildung von Thomas Kudsk Larsen
Copenhagen Business School | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
SANOFI | Health Technology |
Private Unternehmen | 1 |
---|---|
Roche Holdings, Inc.
![]() Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Finance |